The Bind Research team has grown again!

We’re delighted to welcome three new members in 2026.

Dr Hannah Kiely-Collins joins as Senior Scientist, Chemoproteomics. A chemical biologist specialising in chemoproteomics and proximity-inducing modalities, Hannah previously worked at the Francis Crick Institute on translational projects spanning oncology, schizophrenia, and inflammatory bowel disease. At Bind, she will establish a chemoproteomics platform for IDP ligand discovery in native biological systems.

Dr Pijush Chakraborty joins as Senior Scientist, Magnetic Resonance. A structural biologist and biophysicist with deep expertise in protein aggregation, Pijush brings detailed mechanistic insight into dynamic assemblies involving tau and α-synuclein, and will build pipelines to study IDP–small molecule interactions.

Dr Laura Fletcher joins as Director of Strategic Partnerships and part of the leadership team. A life sciences commercialisation expert with over 25 years’ experience in biotech partnerships, licensing, and venture creation, Laura was previously at Deep Science Ventures and Cancer Research UK, and will lead commercial and non-profit partnerships to advance our mission.

Welcome to the team, Hannah, Pijush and Laura!